Category Archives: DNA

Feral DNA may help domestic rabbits thrive in the wild, a new analysis suggests, shedding new light on the evolution of an animal that can cause major environmental destruction.

Publishing in Nature Ecology & Evolution, researchers looked at the relationship between rabbit genetics and feralization, an evolutionary process in which the descendants of domestic rabbits that live in the wild shed characteristics that helped them survive in human settings, taking on those of feral animals instead.

The researchers sequenced DNA from 297 rabbits in six populations in South America, Europe and Australia, all places where rabbits were introduced within the past 200 years. They compared the genetic information with the DNA of other wild and domestic rabbits.

To their surprise, the researchers discovered that all of the rabbits studied had a mixture of wild and domestic DNA.

This was not what we had expected to find, Leif Andersson, a professor of veterinary integrative biosciences at the Texas A&M University School of Veterinary Medicine and Biomedical Sciences and a co-author of the study, says in a news release. We expected that feral rabbits were domestic rabbits that have somehow relearned how to live in the wild. But our findings show us that these rabbits already had a portion of wild DNA helping them survive in nature.

The researchers found that the descendants of domestic rabbits quickly shed the docility and coat colors that humans prefer in pet bunnies, trading them for characteristics that help them thrive in the wild.

That might explain why rabbits in Australia, a continent now overrun with wild bunnies, didnt immediately take over when domestic rabbits were first introduced. The rabbit population surged only after 1859, when the introduction of just 24 wild and domestic rabbits began a population boom that continues to this day.

Today, there are at least 150 million feral rabbits in Australia. The animals are considered invasive pests, competing with livestock and native animals, destroying native plants and crops, and even affecting groundwater absorption.

Excerpt from:
Domesticated rabbits can rewild thanks to feral DNA, study finds - The Washington Post

The road to Olympic gold might seem paved with sweat and genetics, but for three-time gymnastics champion Gabby Douglas, the reality is more complex.

During her most recent comeback attempt, she encountered a fascinating paradox: While dedication and diet have undoubtedly shaped her athletic potential, the precise influence of her own genetics remained a mystery, leaving Douglas to wonder how she can optimize her performance moving forward. Douglas has joined forces with Ancestry and 17 world-class athletes to unlock the secrets her genes hold, aiming to optimize her performance and conquer the podium once again.

Douglas first set foot in the world of gymnastics courtesy of her sister, Arielle. A triple threat with a background in cheerleading, gymnastics, and ballroom dancing, Arielles skills captivated Douglas, sparking a fire that would soon become a lifelong passion.

At just three years old, Douglas was already tumbling into the world of gymnastics, her tiny hands and feet pattering against the mat as she chased after her sisters lead. Arielle, delighted to share her own love for the sport, took Douglas under her wing and began teaching her the basics.

As Douglas grew, so did her skills. By the time she was six years old, she was already taking matters into her own hands or rather, her own feet teaching herself new tricks and stunts like cartwheels and backflips. By eight, she won her first competition.

Douglas would go on to have an illustrious career, securing three Olympic gold medals and making history as the first Black American gymnast to win gold in the Olympic all-around in London in 2012. She also became the first U.S. gymnast to win gold in both the individual all-around and team competitions at the same Olympics cementing herself as one of the greatest gymnasts ever at 20 years old.

But Douglas road was not easy. During her career, Douglas endured vitriolic media criticism, including racist, sexist, and bigoted comments about her hair. In 2016 she stepped away from competition to prioritize her mental health, a pivotal decision that would ultimately allow her to reclaim her identity, rewrite her narrative (on her own terms), and rekindle her passion for gymnastics.

This year, Douglas began her comeback to competition after an eight-year hiatus, only for her attempt to be derailed by a serious ankle injury before the U.S. National Championships. But this injury is not stopping the 28-year-old gymnastics legend. Despite the setback, Douglas is determined to continue competing, telling theGrio that while bittersweet, this obstacle marks the end of a chapter, but not the end of her gymnastics career. Shes set her sights on the 2028 Olympics, and if successful, at age 32, Douglas would make history as the oldest gymnast to compete in the Olympic Games. To defy the odds, though, shes on a mission to unlock the secrets her genes hold, seeking answers on how to optimize her athletic potential and reach the peak of her game once again.

Douglas is not unique in her quest to repeat or return to athletic dominance, but a lingering question persists: What drives the competitive fire within her, and how do genetic factors influence an athletes ability to acquire new skills and re-master old ones as they navigate the physical changes that come with age?

Douglas athleticism and competitive nature appear to run deep, with a great-great-grandfather who served as a porter for the 1912 Mens National Gymnastics team. Modern science backs this up: a recent DNA test by Ancestry reveals genes linked to athleticism in Douglas. These include a natural inclination towards team sports, alongside qualities essential for elite gymnasts like flexibility, strength, and a high overall athletic potential.

Still, the test did highlight areas for improvement, including balance and technique. I was surprised to see that I wasnt naturally good at something like balance, said Douglas who reflected on the results during our interview, but when I think about my career, I wasnt very good at the beam. I had to work hard to be consistent and solid, she continued.

The test results also revealed that Douglas has a remarkably high pain tolerance a cringeworthy finding, given the unfounded and long-standing myth that Black women experience pain differently than women of other races. However, Douglas own experiences confirm this notion.

I have a high pain tolerance, she said. In 2015, I hyperextended my leg while vaulting and heard a loud snap. Despite being compromised, I continued to compete. It wasnt until after returning from Scotland that I realized I needed to get [my injury] checked out and it turned out I had a significant break in my leg. Douglas has since learned the importance of addressing injuries promptly, acknowledging that the intensity of competition can lead to ignoring or downplaying injuries. However, she is now prioritizing the healing of her current foot injury, ensuring it is fully recovered before returning to competition.

As Douglas moves forward, she plans to use her newfound insights to focus on improving her weaknesses and refining her skills, but her primary focus is on supporting her teammates as they compete in this years Paris Olympics. Theres no doubt, however, that the flying squirrel (a nickname given to her by national team coordinator Martha Karolyi), armed with new knowledge, her trademark work ethic, and determination, is well-poised to make a triumphant comeback to the sport she loves. Well be watching.

Dr. Shamard Charles is the executive director of graduate studies in public health at St. Francis College and sits on the Medical Advisory Board of Verywell Health (Dot Dash-Meredith). He is also host of the health podcast, The Revolutions Within Us. He received his medical degree from the Warren Alpert Medical School of Brown University and his Masters of Public Health from Harvards T.H. Chan School of Public Health. Previously, he spent three years as a senior health journalist for NBC News and served as a Global Press Fellow for the United Nations Foundation. You can follow him on Instagram @askdrcharles or Twitter @DrCharles_NBC.

Read this article:
How Gabby Douglas is using DNA tech in her comeback bid - TheGrio

DNA, fingerprints lead to mans arrest over 20 years after Las Vegas-area womans stabbing death  KLAS - 8 News Now

Read the original:
DNA, fingerprints lead to mans arrest over 20 years after Las Vegas-area womans stabbing death - KLAS - 8 News Now

DNA expert confirms at least one type of the Nazca Mummies is part of the Genetic Tree of Life  Marca English

Read the original:
DNA expert confirms at least one type of the Nazca Mummies is part of the Genetic Tree of Life - Marca English

Rosalind Franklin birthday: Story of the forgotten heroine of science who helped sequence DNA  WION

Read the rest here:
Rosalind Franklin birthday: Story of the forgotten heroine of science who helped sequence DNA - WION

Exclusive: Sony confirms it is killing its formidable 5.5TB cartridge storage solution clearing the way for emerging ceramic, silica and DNA storage rivals to take its place  TechRadar

Excerpt from:
Exclusive: Sony confirms it is killing its formidable 5.5TB cartridge storage solution clearing the way for emerging ceramic, silica and DNA storage...

(July 18, 2024)Today, Attorney General Andrew Bailey of Missouri filed awrit of prohibition asking the Missouri Supreme Court to block theCircuit Court of St. Louis Countyfrom hearing the DNA evidence that proves Marcellus Williamss innocence. The circuit court had recentlyscheduled a hearing for August 21 to assess the clear and convincing evidence of actual innocence that led Prosecuting Attorney Wesley Bell to move to vacate Mr. Williamss wrongful conviction and death sentence. Despite overwhelming evidence of his innocence, Missouri has scheduled Mr. Williams for execution on September 24, 2024.

Below is a statement from Tricia Rojo Bushnell, one of Marcellus Williamss attorneys followed by case background:

Instead of using the offices time and resources to review the merits of Marcellus Williamss innocence claim, the Attorney General seeks to delay a court from even hearing the evidence until it is too late. Indeed, when the prosecutor filed a motion to vacate Mr. Williamss conviction in January, the Attorney General told the circuit court it was planning to file an oppositionbut waited four monthsuntil after an execution date was setto argue the court cannot hear the case. The evidence could have been heard in those four months. It can still be heard now. Instead of trying to prevent the circuit court from considering the DNA evidence that exonerates Mr. Williams, the Attorney General should join us in this truth-seeking process in Mr. Williamss case.

-Tricia Rojo Bushnell, attorney for Marcellus Williams

Background on Marcellus Williamss Innocence Case

DNA Evidence Proves Marcellus Williams is Innocent and the Prosecuting Attorney Seeks to Vacate His Wrongful Conviction, Yet Missouri has Scheduled His Execution for September 24

Marcellus Williams is scheduled to be executed on September 24 for a crime DNA proves he did not commit. The St. Louis County Prosecuting Attorney reviewed these DNA results and filed amotion to vacateMr. Williamss conviction because he believed the DNA results proved by clear and convincing evidence that Mr. Williams did not commit this crime. The circuit court has scheduled a hearing for August 21 to consider the exculpatory evidence and resolve the prosecuting attorneys motion.

A crime scene covered with forensic evidence contained no link to Mr. Williams

Mr. Williams has been seeking to prove his innocence throughout the 24 years he has spent on Missouris death row. On August 11, 1998, Felicia Gayle, a former reporter for theSt. Louis Post-Dispatch, was found stabbed to death in her home. The perpetrator left behind considerable forensic evidence, including fingerprints, a bloody shoeprint, hair, and trace DNA on the murder weapon, a knife from Ms. Gayles kitchen.None of this forensic evidence matches Mr. Williams.

A case built on snitch witnesses

The case against Mr. Williams turned on the testimony of two unreliable witnesses who were incentivized by promises of leniency in their own pending criminal cases and reward money. The investigation had gone cold when a jail inmate named Henry Cole, a man with a lengthy record, claimed that Mr. Williams confessed to him, while they were both locked up in jail, that he committed the murder. Cole directed police to Laura Asaro, a woman who had briefly dated Mr. Williams and had an extensive record of her own.

Both of these individuals were known fabricators; neither revealed any information that was not either included in media accounts about the case or already known to the police. Their statements were inconsistent with their own prior statements, with each others accounts, and with the crime scene evidence, and none of the information they provided could be independently verified. Aside from their testimony, the only evidence connecting Mr. Williams to the crime was a witness who said Mr. Williams sold him a laptop taken from the victims home, but the jury did not learn that Mr. Williams told the witness he had received the laptop from Laura Asaro.

New DNA testing confirms Mr. Williams is innocent yet no court has considered that evidence

As he has fought to prove his innocence, Mr. Williams has repeatedly faced imminent execution. To date, no court has given substantive consideration to the evidence exonerating him; the August 21 hearing will be the first time a court engages in that review.

Nine years ago, the Missouri Supreme Court stayed Mr. Williamss execution and appointed a special master to review DNA testing of potentially exculpatory evidence.This testing showed that Mr. Williams was not the source of male DNA found on the murder weapon.

However, in 2017, after the testing was completed but without conducting a hearing or making any findings based on the outcome of the testing, the appointed special master sent Mr. Williamss case back to the Missouri Supreme Court. That court, also without considering the DNA testing results, again scheduled Mr. Williamss execution.

Recognizing that the new evidence raised serious doubts about Mr. Williamss guilt, on August 22, 2017, mere hours before his execution and after his last meal, then-Governor Eric Greitens stayed the execution and convened a Board of Inquiry to investigate the case. Under Missouri law, the stay was to remain in place until the Board of Inquiry concluded its review and issued a formal report.

Yet in June 2023, while the Board of Inquirys review remained ongoing, Governor Mike Parson without warning or notice dissolved the Board without a report or recommendation from the Board. Missouri Attorney General Andrew Bailey then promptly sought a new execution date. Mr. Williams sued Governor Parson because the dissolution of the Board without a report or recommendation violated the law and Mr. Williamss constitutional rights. The Governor tried to dismiss the lawsuit, but a Cole County civil judge denied that request. The Governor then asked the Missouri Supreme Court to intervene. The Missouri Supreme Court agreed to do so and on June 4, 2024, it dismissed the lawsuit and immediately scheduled Mr. Williamss execution for September 24, 2024.

The St. Louis County Prosecuting Attorney has concluded that Mr. Williams is actually innocent and moved to vacate his conviction

After the exculpatory DNA evidence was brought to his attention, St. Louis County Prosecuting Attorney Wesley Bell appointed a special prosecutor to review Mr. Williamss case. The special prosecutor reviewed the findings of three independent DNA experts. All three concluded that Mr. Williamswas not the source of male DNA on the weapon,and therefore could not have killed Ms. Gayle. Mr. Williamss exclusion from the murder weapon is consistent with his exclusion from other forensic evidence collected from the crime scene including a bloody shoeprint and hairs found near the victims body.

Recognizing that new evidence suggests that Mr. Williams is actually innocent (p.3), in January 2024 the St. Louis County Prosecuting Attorney filed amotion to vacateMr. Williamss conviction. The motion explains: DNA evidence supporting a conclusion that Mr. Williams was not the individual who stabbed Ms. Gayle has never been considered by any court. This never-before-considered evidence, when paired with the relative paucity of other, credible evidence supporting guilt . . . casts inexorable doubt on Mr. Williamss conviction and sentence. (p.1) The Prosecuting Attorney urged the circuit court to begin the process of correcting this manifest injustice by [holding] a hearing on the newfound evidence and the integrity of Mr. Williamss conviction. (p.3)

The Missouri Attorney General continues its history of fighting innocence cases

Although the Prosecuting Attorneys motion remains pending and the law requires the circuit court to hold a hearing on it, as that court recognized, the Missouri Attorney General has taken the position that Mr. Williamss innocence does not matter, and the Missouri Supreme Court has scheduled his execution.

The Missouri Attorney Generals office has argued in other death penalty cases that even DNA evidence of innocence is not enough to stop an execution. In a2003 oral argument before the Missouri Supreme Court, Justice Laura Denvir Stith asked Assistant Attorney General Frank Jung, Are you suggesting even if we find that Mr. Amrine is actually innocent, he should be executed? That is correct, your honor, Jung replied. The Missouri Supreme Court ultimately disagreed, and Amrine was exonerated. But over 20 years later, the same arguments are still being made.

The Missouri Attorney Generals Office has opposed every innocence casefor the last 30 years,including every attempt made by a local prosecutorto overturn a conviction on the basis of innocence, as the St. Louis County Prosecuting Attorney is doing in Mr. Williamss case. In 2021 and 2023 Kevin Strickland and Lamar Johnson were exonerated despite the Attorney Generals attempts to thwart the prosecutors motions to vacate.

Incentivized informants are a leading cause of wrongful convictions

Jailhouse informant testimony like that leading to Mr. Williamss conviction is one of the leading contributing factors of wrongful convictions nationally, playing a role in15% of DNA exoneration cases.Eleven of the54individuals exonerated in Missouri were convicted with the use of informant testimony.

In capital cases, false testimony from incentivized witnesses is theleading cause of wrongful convictions, with informant testimony present in 49.5% of wrongful convictions since the mid-1970s (Source: Warden, R. 2005.The snitch system: How snitch testimony sent Randy Steidl and other innocent Americans to death row. Center on Wrongful Convictions.)

Racial bias contributed to Mr. Williamss wrongful conviction

Mr. Williams, a Black man, was wrongfully convicted of murdering a white woman. His jury was comprised of 11 white people and only one Black person. The prosecutor, whose institutional practice of racially discriminatory jury selection has been widelydocumented, successfully removed six of seven qualified Black prospective jurors with peremptory challenges. Arecent studyof 400 death-eligible cases in St. Louis County over a 27 year period also revealed racial disparity in the use of the death penalty based upon the race of the victim. Defendants were 3.5 times more likely to receive the death penalty if the victim was white, as in this case, compared to if the victim was Black.

Mr. Williams is devoutly religious and an accomplished poet

During his 24 years in prison, Mr. Williams has devoted much of his time to studying Islam and writing poetry. He serves as the imam for Muslim prisoners at Potosi Correctional Center and is known as Khaliifah. He has an exemplary prison record and is widely respected within the prison community and beyond.

Read more about Marcellus Williamss case atwww.savemarcellus.orgorwww.marcelluswilliams.org.

See original here:
Missouri AG Asks Missouri Supreme Court to Block Hearing on DNA Evidence Proving Marcellus Williams' Innocence - Innocence Project

Cas12 nucleases offer diverse yet complex opportunities for tracrRNA reprogramming

Type V CRISPR-Cas systems comprise numerous systems that involve tracrRNAs that could be amenable to tracrRNA engineering. Of the 14 subtypes of type V systems defined to-date, eight (associated with Cas12b, Cas12c, Cas12d, Cas12e, Cas12f1, Cas12g, Cas12k and Cas12l) exclusively rely on a tracrRNA for gRNA biogenesis (Fig.1b)5,6,11,34,35,36,37,38,39,40,41,42,43. For the remaining systems, the Cas12 nuclease directly recognizes and processes the transcribed repeat, as commonly demonstrated for Type V-A systems and its Cas12a nuclease7,11,44,45,46,47. Apart from collateral cleavage activity9,12,35,38,48, some or all of these DNA-targeting nucleases possess features distinct from more traditional Cas9 nucleases, such as pre-crRNA processing38,49,50, compact nucleases39,40,41,42,48,51, higher optimal temperatures9,36,52, crRNA-guided transposition37,53 and T-rich and C-rich PAM recognition6,11,43,49.

TracrRNA reprogramming involves engineering the anti-repeat region to hybridize with an RNA-of-interest while maintaining the essential sequence and structural features of the natural repeat/anti-repeat (R/AR) duplex recognized by the Cas nuclease. While Cas9-associated RNA duplexes form a simple 2540bp stem typically interrupted by a small bulge54,55,56, Cas12-associated RNA duplexes adopt distinct and more complicated conformations (Fig.1c). In addition to a long repeat/anti-repeat (LR/AR) stem often containing an intervening bulge, the reported duplexes associated with Cas12b, Cas12f1, Cas12g and Cas12l also possess a pseudoknot that includes a 57bp short repeat/anti-repeat (SR/AR) stem6,15,43,57,58,59,60. For Cas12e and Cas12k, the reported RNA duplexes possess a 3-bp triple helix formed by two portions of the anti-repeat sandwiching the repeat in addition to the bulged LR/AR stem35,53,61,62 (Fig.1c and Supplementary Fig.1). Finally, for Cas12c, the reported RNA duplexes form three 4-7bp disjoint R/AR stems49 (Fig.1c). Given the diversity and complexity of these RNA duplexes, we explored the extent to which the RNA duplexes associated with these diverse tracrRNAs can be reprogrammed for RNA detection.

We started with the Bacillus hisashii Cas12b (BhCas12b) due to the relative simplicity of its RNA duplex comprising a 30-bp LR/AR stem with an intervening bulge, and a 5-bp SR/AR duplex between the LR/AR and the guide36,57 (Fig.2a). We sought to investigate the reprogrammability of both stems using a Cas12 cleavage assay conducted with a cell-free transcription-translation (TXTL) system63. As part of the assay, purified BhCas12b protein, a gRNA-expressing plasmid and a plasmid encoding the PAM-flanked dsDNA target upstream of a GFP reporter construct were added to a reaction, and we monitored fluorescence over time. Cleavage of the reporter construct leads to loss of GFP expression through rapid degradation of the linearized DNA (Fig.2b).

a Predicted tracrRNA-crRNA structure for BhCas12b based on its ortholog BthCas12b (PDB: 5WTI57). R/AR, repeat/anti-repeat. b Setup to assess Rptr functionality using cell-free transcription-translation (TXTL). Expressed Cas-guide RNA complex recognizes and cuts its dsDNA target, causing the degradation of target-encoding GFP reporter plasmid and resulting in lower fluorescence compared to a non-targeting guide control. c 16-hourendpoint fluorescence measurements in TXTL when changing the long and short RNA duplexes. NT, non-targeting guide; T, targeting guide; T-br, targeting crRNA with bulge removed. d Setup to reprogram tracrRNAs to sense a Campylobactor jejuni transcript CJ8421_04975 mRNA. The guide and target components are added in the form of DNA constructs, while the purified BhCas12b protein is used. mRNA(mut), mRNA with point mutations in the predicted seed region of the guide. Rptr(scr-LA), Rptr with the long anti-repeat sequence scrambled; Rptr(scr-SA), Rptr with the short anti-repeat sequence scrambled; Rptr(scr-LA&SA), Rptr with both long and short anti-repeat sequence scrambled. e 16-hourendpoint fluorescence measurements in TXTL when assessing Rptr-guided sequence-specific dsDNA targeting. Nucleotide changes in R/AR stems in c and d are indicated by gray boxes. Bars and error bars in c, e represent the mean and standard deviation from three independently mixed TXTL reactions. Dots represent individual measurements. ***p<0.001 based on a one-sided Students t-test with unequal variance (n=3). Source data are provided as a Source Data file.

To interrogate the reprogrammability of the crRNA-tracrRNA duplex, we began with the intervening bulge in the crRNA-tracrRNA duplex followed by the two stems. Previous studies showed that a bulge in the LR/AR duplex is necessary to maintain the dsDNA targeting activity for SpyCas9 and Sth1Cas955. However, removing this bulge from the LR/AR associated with BhCas12b did not impinge on GFP silencing (Fig.2c), likely due to the bulge falling outside of the nuclease binding region57. Using the bulge-removed variant as a baseline to interrogate programmability of the LR/AR and SR/AR RNA stems (Fig.2c), we found that both stems could be reprogrammed without impinging on GFP silencing, whether changing the lower or upper portion of the LR/AR stem (cr1-4) or the SR/AR stem (cr5-6). The crRNA-tracrRNA duplex could be similarly reprogrammed for the Bacillus thermoamylovorans Cas12b (BthCas12b)57, as changes in the LR/AR and SR/AR of a fusedsingle-guide RNA (sgRNA) were well tolerated (Supplementary Fig.2). Therefore, tracrRNAs associated with Cas12b nucleases are highly amenable to reprogramming.

We next explored the extent to which the BhCas12b Rptr could be applied for RNA detection. We started with the CJ8421_04975 mRNA previously used to evaluate Rptrs associated with different Cas9 nucleases31. Two Rptrs hybridizing at different loci of CJ8421_04975 mRNA were designed based on rules derived from our mutational analysis of the LR/AR and SR/AR (Fig.2c and Supplementary Fig.3). Strong GFP silencing was observed for both BhRptr1 and BhRptr2 when compared with the non-targeting crRNA control, and both Rptrs combined with the mRNA exhibited similar performance as their equivalent crRNA/tracrRNA pairs (Fig.2d, e). Furthermore, dsDNA targeting occurred specifically through the predicted guide sequence, as mutating the predicted seed region or scrambling the tracrRNA anti-repeat (long, short or both) fully inhibited GFP silencing. The one exception was scrambling the anti-repeat of the tracrRNA associated with locus 1 of the mRNA, which still maintained substantial targeting activity likely due to shifted base pairing in the short duplex (Fig.2d, e). Overall, the Cas12b tracrRNA can be reprogrammed to link an RNA-of-interest to sequence-specific dsDNA targeting.

Building on the reprogramming of Cas12b tracrRNAs, we turned to the Acidibacillus sulfuroxidans Cas12f1 (AsCas12f1) from Type V-F CRISPR-Cas systems39,64. While its crRNA-tracrRNA duplex parallels that associated with BhCas12b (Fig.3a), AsCas12f1 is a much smaller protein and forms a homodimer when binding a single crRNA-tracrRNA duplex. Using the TXTL assay with plasmid-expressed AsCas12f1 and an sgRNA, we found that the intervening bulge was also dispensable and the LR/AR and SR/AR could be fully reprogrammed without impinging on GFP silencing (Fig.3b). The base-pairing in the SR/AR was crucial for dsDNA targeting, as deletion of the SR portion of the SR/AR or mismatches in the SR/AR substantially inhibited GFP silencing (Fig.3b). We further demonstrated that three Rptrs designed to hybridize to different loci in the CJ8421_04975 mRNA yielded GFP silencing with comparable performance as their equivalent crRNA/tracrRNA counterparts in TXTL (Fig.3c, d). As before, mutating the seed region in the predicted guide or scrambling the tracrRNA anti-repeat (long, short or both) fully inhibited GFP silencing.

a AsCas12f1 sgRNA structure (PDB: 8J1264). See the detailed information in Supplementary Fig.1. b 16-hourendpoint fluorescence measurements in TXTL when reprogramming the long and short RNA duplexes in theAsCas12f1 sgRNA. NT, non-targeting crRNA; T, targeting crRNA. c Setup to detect the Campylobacter jejuni transcript CJ8421_04975 mRNA using AsCas12f1 Rptrs in TXTL. d 16-hourendpoint fluorescence measurements in TXTL for Rptr-guided sequence-specific dsDNA targeting by AsCas12f1 in TXTL. e Structure of DpbCas12e sgRNA (PDB: 6NY3)35. In the triple-helix region, a cis Hoogsteen/Watson-Crick base pair is formed between the U.A and a cis Watson-Crick/Watson-Crick base pair between the A-U. f 16-hourendpoint fluorescence measurements in TXTL when assessing the changeability of the LR/AR region. Dpb_T-br, targeting sgRNA with thebulge and G.U wobble base pair removed. g 16-hourendpoint fluorescence measurements in TXTL when changing the RNA triple-helix region. h 16-hourendpoint fluorescence measurements in TXTL when changing the RNA triple-helix surrounding region. i, Setup to detect the Campylobacter jejuni CJ8421_04975 mRNA using DpbCas12e Rptrs in TXTL. j, 16-hour endpoint fluorescence measurements for Rptr-guided sequence-specific dsDNA targeting by DpbCas12e in TXTL. Rptr(scr-dplx), Rptr with a scrambled anti-repeat sequence; Rptr(scr-tplx), Rptr with the RNA triple-helix sequence scrambled; Rptr(scr-d&tplx), Rptr with the RNA duplex and triple-helix sequence scrambled. Nucleotide changes in AsCas12f1 sgRNA and DpbCas12e sgRNA in b, f, g and h are indicated by gray boxes. Bars and error bars in b, d, f, g, h, and j represent the mean and standard deviation from three independently mixed TXTL reactions. Dots represent individual measurements. No error bars are shown when only two replicates were successfully collected. *: p<0.05. **: p<0.01. ***:p<0.001 based on a one-sided Students t-test with unequal variance (n=3). Source data are provided as a Source Data file.

Deviating from Cas12b and Cas12f1, Cas12e nucleases rely on crRNA-tracrRNA duplexes containing an RNA triple helix instead of a pseudoknot (Fig.3e and Supplementary Fig.1)35,53,61,62, posing an even greater challenge for RNA detection with PUMA. We selected the previously characterized Deltaproteobacteria Cas12e (DpbCas12e)35 and evaluated the reprogrammability of the bulged stem as well as the triple helix. Paralleling BhCas12b and AsCas12f1, removing the bulge and a G-U wobble pair in the context of an sgRNA did not compromise GFP silencing, and the stem could be readily reprogrammed (Fig.3f). Turning to the triple helix, this helix is formed by two separate tracts of three uracils at the 5 end of the tracrRNA sandwiching three adenosines in the repeat (Fig.3e and Supplementary Fig.1)35. A cis Hoogsteen/Watson-Crick base pair forms between the U.A and a cis Watson-Crick/Watson-Crick base pair forms between the A-U, assigning the triple helix to the cWW/cHW triple family65. RNA triple-helix motifs are found in various functional RNAs, such as telomerase RNAs66,67, riboswitches68 and long noncoding RNAs69,70. Despite its diversified distribution, the changeability of RNA triple helix in these biologically important RNAs has not been systematically investigated.

We reasoned that other RNA triple helices in the same cWW/cHW family might preserve dsDNA targeting by DpbCas12e. Using the RNA Base Triple Database as a reference71, we tested all nine RNA triple helix combinations reported in existing functional RNAs (s11-s18, and the native U.A-U), three expected to form a triple helix but not observed to-date (s19-21), and two not expected to form a triple helix and not observed to-date (s22-23, Fig.3g). Among the 14 tested triple-helix combinations, two (C.G-U_s11, C.G-C_s18) yielded GFP silencing comparable to that of the native U.A-U. In addition, installing the combination of U.A-U and C.G-C base triples in the RNA triple-helix region (s24-26) also yielded comparable GFP silencing. As expected, disrupting the RNA triple-helix conformation in one of thethree triples in the triple-helix region abolished dsDNA targeting (s27-32, Fig.3g), indicating a stringent triple-helix conformation required by DpbCas12e.

The RNA triple-helix region is surrounded by one C-G base pair at the 3 end and three unpaired nucleotides (AUC) at the 5 end of the repeat that may also represent necessary sequence or structural features (Fig.3h). For the C-G base pair, we found that introducing a C.A mismatch (s33) fully abolished silencing, while changing the base pair to U-A (s34) only modestly reduced GFP silencing (Fig.3h). For the AUC at the 5 end, mutating the C to A, G and U (s35-s38) resulted in similar or even improved GFP silencing (Fig.3h). The U could also be replaced with other nucleotides (s39-s41) without compromising activity (Fig.3h). Changing the A to C or G (s42, s44) was also well tolerated, while changing the A to U (s43) substantially inhibited GFP silencing (Fig.3h). Together, the RNA duplex and triple-helix regions are reprogrammable, albeit with less flexibility for the triple-helix region (Supplementary Fig.2).

Based on the insights from the systematic mutational analyses to DpbCas12e sgRNA, we designed three Rptrs targeting different loci in CJ8421_04975 mRNA (Fig.3i). We observed substantial GFP silencing for all three designed Rptrs, with comparable performance to that of their equivalent crRNA:tracrRNA pairs. As before, mutating the seed region in the predicted guide or scrambling the tracrRNA anti-repeat inhibited GFP silencing (Fig.3j). Overall, Rptrs could be extended to different Cas12 nucleases with varying tracrRNA-crRNA structures.

In contrast to Cas9, Cas12 non-specifically cleaves ssDNA upon target recognition, enabling signal amplification as part of CRISPR-based diagnostics2. We therefore reasoned that combining Rptrs, dsDNA targets, and ssDNA reporters would couple RNA detection by Cas12 to an amplified readable outputthe basis of PUMA. To assess the collateral effects of BhCas12b, we devised an in vitro collateral cleavage assay using purified BhCas12b protein, in vitro-transcribed sgRNAs or sensed RNAs and Rptrs, linear dsDNA targets and a ssDNA fluorophore-quencher reporter (Fig.4a). Upon recognition and cleavage of its dsDNA target, the nuclease non-specifically cleaves the fluorophore-quencher reporter, resulting in an increase in fluorescence.

a Schematic ofthe in vitro trans-cleavage assay. The assay includes purified aCas12 nuclease, anin vitro transcribed Rptr, and alinear dsDNA target. The Cas12-guide RNA ribonucleoprotein (RNP) recognizes and cleaves its dsDNA target, which triggers non-specific cleavage activity on ssDNA. Specifically, cleavage of the non-target strand (NTS) occurs before cleavage of the target strand (TS). F, fluorophore; Q, quencher. Yellow circle, PAM; b Impact of unprocessed or processed targets on in vitro trans-cleavage activity by BhCas12b. TS cleavage is the rate-limiting step. Red arrow, cleavage site. The cleavage site of TS is set as position 0. -, truncating the target sequence on NTS or TS. +, adding an overhang on NTS or TS. The PAM is in brown and the target is in blue. c, Direct detection of the full-length CJ8421_04975 mRNA by BhCas12b based on in vitro collateral cleavage activity. Yeast RNA is added in the same mass amount as the 1000nM sensed mRNA, and the best-performing dsDNA target NTS-6: TS-2 is used. d, Impact of unprocessed or processed targets on in vitro collateral cleavage activity by DpbCas12e. e Direct detection of the full-length CJ8421_04975 mRNA by DpbCas12e based on in vitro collateral cleavage activity. Yeast RNA is added in the same mass amount as the 1000nM sensed mRNA, and the best-performed dsDNA target NTS-8: TS-4 is used. 16h end-point values were used to make theplots in c and e. See Supplementary Figs.6b and 10a for the complete time courses. Curves in b and d represent the mean from two independent collateral assays. Bars anddots in c and e represent the mean andindividual measurements, respectively, from two independent collateral cleavage assays. Light blue bars indicate the limit-of-detection (LOD) conservatively estimated as the lowest concentration yielding an average fluorescence exceeding 50% of that of the no-RNA control. Source data are provided as a Source Data file.

We began with an sgRNA and a 334-bp linear dsDNA containing a 27-bp PAM-flanked target, with the resulting in vitro reaction conducted at 37C (Supplementary Fig.4a). We observed slight background fluorescence without the dsDNA target and monotonically increasing fluorescence with the dsDNA target that plateaued after 12hours (kobs=0.03h1, Supplementary Fig.4b, Supplementary Data1), in line with cis-cleavage of the dsDNA target triggering multi-turnover collateral cleavage of the fluorescent ssDNA reporter by BhCas12b. The activity exhibited by BhCas12b was weaker compared to that by FnCas12a (kobs=0.11h1), DpbCas12e (kobs=0.65h1) and LbCas12a (kobs=2.1h1) under equivalent conditions (Supplementary Fig.4b, Supplementary Data1). Elevating the temperature from 29 to 42C increased the reaction rate by 1.7-fold (kobs=0.19h1 at 42C) (Supplementary Fig.4c, Supplementary Data1), in line with higher temperatures yielding optimal cleavage activity for Cas12 nucleases9,36,52.

With an in vitro collateral cleavage assay in place, we next turned to the dsDNA target. Standard Cas12-based diagnostics have little control over the composition of the dsDNA target without extensive manipulations. In contrast, the dsDNA targetis provided as part of PUMA, granting complete control over its sequence, length, and chemistry. This control in turn could be leveraged to enhance the reaction. As a start, we evaluated the impact of using targets encoded on shorter linear DNA, perceivably by reducing the search time for the target sequence. In line with this rationale, we observed a 5.6-fold increase in collateral cleavage activity at 37C when shortening the dsDNA target length from 334bp (kobs=0.03h1) to 94bp (kobs=0.17h1). However, collateral cleavage activity decreased when shortening the DNA length to 60bp (kobs=0.12h1) or to 48bp (kobs=0.08h1) (Supplementary Fig.4d, Supplementary Data1). We also tested ssDNA targets, which exhibited at least a 2-fold increase in collateral activity than dsDNA targets of equivalent size (Supplementary Fig.5), in line with circumventing PAM recognition and DNA unwinding. We continued to use dsDNA targets though due to their more stringent and specific target recognition2.

The observed impact of DNA length on signal production led us to explore a distinct aspect of the dsDNA target: the extent of cleavage by Cas12 nucleases. Upon target recognition, Cas12 nicks the non-target strand followed by the target strand of the dsDNA target through the nucleases RuvC domain72,73, leading to a cleaved dsDNA target with a 5 overhang (Fig.4a). Complete cleavage of the dsDNA target normally precedes collateral cleavage72, with target strand cleavage posing the rate-limiting step36,73,74,75. We therefore hypothesized that using a dsDNA target with a processed target strand would increase the observed rate of collateral cleavage. In line with this hypothesis, a dsDNA target with a processed non-target strand yielded similar collateral cleavage rates to that of an unprocessed dsDNA target (kobs=0.06 - 0.16h1) at 37C for dsDNA lengths ranging between 45 and 94bp (Fig.4b, Supplementary Fig.6a, b, and Supplementary Data1). In contrast, a dsDNA target with a processed target strand yielded increased collateral cleavage rates (kobs up to 0.46h1 for NTS+55: TS+0), in line with target strand cleavage posing the rate-limiting step (Fig.4b and Supplementary Fig.6a, b). A similar collateral cleavage rate (kobs=0.44h1) was observed for a dsDNA target with both strands processed (NTS-6: TS+0) (Supplementary Fig.6a, b). Finally, trimming the target strand by two additional nts towards the PAM can further enhance the observed collateral cleavage activity (NTS-6: TS-2, kobs=0.56h1) (Supplementary Fig.6a, b). With conditions established for enhanced RNA detection using BhCas12b, we turned to detecting the full-length CJ8421_04975 mRNA using BhRptr4 in vitro. Under the optimal conditions with the shortest and processed dsDNA target (NTS-6:TS-2) at 42C, the sensed mRNA was detected at 1M in 45minutes and at 10nM in 16hours based on endpoint measurements compared to a no-RNA control (Fig.4c and Supplementary Fig.6c).

The optimized experimental setup with BhCas12b allowed us to assess how the ability of the sensed RNA and Rptr to hybridize impacts collateral cleavage activity. One potential factor is the formation of internal secondary structures that hinder hybridization. To test this factor directly, we introduced extensions to the 5 extensions to the ncrRNA associated with BhRptr4 (Supplementary Fig.7). The hairpins reduced collateral cleavage activity, with an internal hairpin inhibiting more strongly than a flanking hairpin. In the absence of these structures, introducing an annealing step did not enhance collateral cleavage activity (Supplementary Fig.8). Of note, collateral cleavage activity resulting from pairing of thepartial CJ8421_04975 mRNA fragment and BhRptr4 was higher than that obtained with the equivalent sgRNA, indicating that hybridization between a sensed RNA and Rptr is not necessarily a bottleneckto RNA detection.

With factors influencing RNA detection with BhCas12b established, we asked whether increasing the reaction temperature and truncating the dsDNA target also apply to DpbCas12e, which exhibited much higher collateral cleavage activities (Supplementary Fig.4). We tested DpbCas12e with DpbRptr1 against the full-length CJ8421_04975 mRNA along with different-sized dsDNA targets at different temperatures (Supplementary Fig.9ac). Similar to BhCas12b, DpbCas12e exhibited increased activity when elevating the temperature (kobs=0.07h1 at 29C, 0.43h1 at 37C and 0.67h1 at 42C) (Supplementary Fig.9b) and when shortening the length of the dsDNA target (kobs=0.43h1 for 331bp and 0.54h1 for 44bp) (Supplementary Fig.9c). Moreover, introducing a processed dsDNA target increased the collateral cleavage rate (for 91-bp target, kobs=0.46h1 for unprocessed strands, 0.78h1 for processed target strand) (Fig.4d and Supplementary Fig.10a). Finally, under the optimized conditions using the double-strand processed 38-bp dsDNA target at 42C, the sensed mRNA could be detected at a concentration of 1M in 9minutes and at a concentration of 0.1nM in 16hours (Fig.4e and Supplementary Fig.10b). Therefore, different tracrRNA-dependent Cas12 nucleases can be co-opted for direct, PAM-independent RNA detection in vitro.

When comparing collateral cleavage activities across Cas12 orthologs (Supplementary Fig.4b), we noticed that the LbCas12a-gRNA complex produced substantial fluorescence even in the absence of its corresponding dsDNA target, reaching approximately 70% of the levels seen when its dsDNA target is present after 16hours of incubation (Supplementary Fig.4b). A high background activity was also reported for AsCas12a in previous studies76,77. To assess the prevalence of this background activity, we tested four BhCas12b sgRNAs (#1-4, with the #4 guide used with other Cas12 orthologs in FigureS4b) using processed dsDNA targets (NTS-6: TS-2). Substantial DNA target-independent activity was observed for sgRNA#1 and #2, with comparable fluorescence levels to those with the dsDNA targets after 16hours (Fig.5a). Intriguingly, sgRNA#1 exhibited high cleavage activity (kobs=1.02-1.16h1) regardless of the presence or absence of the dsDNA target. This phenomenon was not isolated, as 5 out of 10 additional sgRNAs we tested exhibited DNA target-independent collateral activity higher than that of sgRNA#4 (Supplementary Fig.11).

a, Measured in vitro collateral cleavage activity with BhCas12b and an sgRNA with or without a dsDNA target. b, Measured in vitro collateral cleavage activity with BhCas12b and a Rptr and a dsDNA target with or without the sensed RNA. c, Sensitivity comparison between sgRNA and Rptr. In a-b, 37-bp NTS-2:TS-2 processed dsDNA targets were used for both sgRNA and Rptr. In c, 334-bp DNA fragments containing the core PAM-flanking target were used with the sgRNAs and 37-bp NTS-2:TS-2 processed dsDNA targets were used with the Rptrs. In a-c, sgRNA#1 and sgRNA#4 share the same guide sequences as those generated by Rptr#1 and Rptr#4, respectively. Dots represent individual measurements from two independent collateral cleavage assays. Bars represent the mean of the dots. In a-b, values represent fluorescence measurements after reaction times of 2hours and 16hours. In c, values represent fluorescence measurements after reaction times of 16hours. Light blue bars indicate the limit-of-detection (LOD) conservatively estimated as the lowest concentration yielding an average fluorescence exceeding 50% of that of the no-RNA control. Source data are provided as a Source Data file.

This DNA target-independent collateral activity would reduce the sensitivity of nucleic-acid detection, making it more challenging to identify low-concentration biomarkers. In contrast, we hypothesized that any background activities would be greatly reduced using Rptrs, as the guide RNA is principally formed only in the presence of the sensed RNA. Supporting this hypothesis, combining a sensed RNA and Rptr for BhCas12b drove collateral activity even in the absence of the DNA target (Supplementary Fig.12). In the absence of the sensed RNA, each Rptr alone resulted in endpoint fluorescence levels 3.5-fold to 29.9-fold lower than those observed in the presence of the corresponding sgRNA (Fig.5b). Based on this difference, we directly compared the sensitivity of BhCas12b detecting dsDNA with an sgRNA or detecting the equivalent RNA with a Rptr. The limit-of-detection was around 10-fold lower using a Rptr than an sgRNA for one site (#4), while RNA detection (with a Rptr) but not DNA detection (with an sgRNA) was possible at another site (#1) (Fig.5c). Thus, the sensitivity of nucleic-acid detection with Cas12 nucleases can be enhanced by detecting RNA with Rptrs rather than detecting DNA with sgRNAs, at least depending on the nuclease and detected sequence.

Given the enhanced sensitivity when detecting RNA with PUMA versus dsDNA traditionally detected with Cas12 nucleases, we asked how PUMA compares to the two standard CRISPR-based diagnostic approaches DETECTR for DNA detection with Cas122 and SHERLOCK for RNA detection with Cas134 (Supplementary Fig.13). We chose to detect three loci within the CJ8421_04975 DNA/mRNA and used sensitivity as the basis of comparison. BhCas12b was used for both PUMA and DETECTR to ensure a direct comparison, while PbuCas13b was used for SHERLOCK78. No pre-amplification was included to directly gauge the sensitivity associated with each Cas nuclease. Two of the sites lacked the PAM recognized by BhCas12b, in line with the requirement for a PAM inherent to DETECTR. Of the detected loci, the three approaches performed similarly, with the measured limit of detection either at 1nM or 10nM. Thus, PUMA can perform similarly to DETECTR and SHERLOCK, at least with the tested Cas nucleases, with PUMA targeting a broader range of sites than DETECTR.

One core feature of Rptrs is that base pairing with a sensed RNA is somewhat flexible, whereas the flanking guide sequence should direct dsDNA targeting that is highly sensitive to mismatches31. To exploit this feature, we applied Cas12 Rptrs to differentiate bacterial pathogens based on their 16S rRNA79,80. Differentiating pathogens can be important to select appropriate courses of treatment for different indications such as acute sepsis, urinary tract infections, or sexually transmitted diseases. Traditional CRISPR diagnostics based on collateral cleavage by Cas12 or Cas13-based diagnostics have taken strides in this direction81, with one example using multiple guide RNAs to detect different bacterial pathogens82. In contrast, with this core feature of Rptrs, a single Rtpr could be designed to pair next to a variable region of 16S rRNA indicating the genus. The variable region would then be matched to a dsDNA target, with its cleavage and subsequent collateral activity indicating which pathogen is present.

To determine how to best design the Rptr, we began by evaluating the specificity of the three different Cas12b homologs (BthCas12b, BhCas12b and AacCas12b), with the goal of identifying at least one homolog exhibiting high guide-target mismatch sensitivity. We assessed collateral cleavage activity of each homolog using a Rptr-sensed RNA encoding the same guide sequence along with dsDNA targets containing two consecutive mismatches sliding through the guide-target region (Fig.6a). Among the three orthologs, BthCas12b was the most sensitive to guide-target mismatches, especially in positions 5-12 proximal to the PAM in which the mismatches reduced collateral cleavage activity between 102-fold and 105-fold (Fig.6a). We also evaluated the extent to which BthCas12b accepts mismatches between the sensed RNA and the Rptr (Supplementary Fig.14). Mismatches in the long or short repeat consistently reduced but rarely eliminated activation of collateral cleavage activity even with four consecutive mismatches. This flexibility lends to pairing with conserved 16S rRNA regions with some variability, even if unintended RNA duplexes bound by Cas12 could be generated in the process. We therefore proceeded with BthCas12b and aimed for sequence differences to fall within the most sensitive positions of the target.

a Tolerance of guide-target mismatches for three different Cas12b orthologs based on in vitro collateral cleavage activity. The DNA target is the same as the one used in Fig.4B (BhsgRNA4 DNA target). Heat maps represent the mean kobs valuesfrom two independent collateral assays. See the kobs values in Supplementary Data1. b Setup to differentiate 16S rRNA from five different pathogens using only one universal BthCas12b Rptr binding to a conserved region of 16S rRNA. A truncated long anti-repeat of 18 nts instead of the usual 31 nts is used in the universal Rptr. In the alignment, sequences that match the E. coli 16S rRNA are in black, while those that do not match are shown in red. c Detection of pathogen 16S rRNAs with a universal Rptr and corresponding dsDNA targets based on in vitro collateral cleavage activity with BthCas12b. Partial 16S rRNA fragments of different pathogens at a final concentration of 100nM were used. Values represent 36-minute reaction times. Values in c represent the mean and standard deviation from two independent collateral assays. Source data are provided as a Source Data file.

Following this approach, we designed a single BthCas12b Rptr that hybridizes to a conserved region of bacterial 16S rRNA, with the downstream variable region serving as the guide sequence. We specifically focused on five common bacterial pathogens, E. coli, Klebsiella pneumoniae, Staphylococcus aureus, Enterococcus faecalis, and Listeria monocytogenes (Fig.6b), where the sequence differences fall within the region of mismatchsensitivity for BthCas12b. As before, a PAM did not need to appear within the sensed RNA, as this was encoded within the dsDNA targets. We then assessed collateral cleavage activity for each 16S rRNA fragment and each dsDNA target. The fragment was introduced at a final concentration of 100nM, reflecting the output of isothermal pre-amplification and in vitro transcription2. The presence of the 16S rRNA fragment from one specific pathogen triggers fluorescence release only when paired with its corresponding dsDNA target (Fig.6c and Supplementary Fig.15). We noticed 16S rRNA from L. monocytogenes also gave rise to substantial fluorescence when pairing with the dsDNA target from S. aureus, likely due to the high similarity between their 16S rRNA fragments with only three mismatches present outside of the seed region (Fig.6b, c and Supplementary Fig.15). Thus, specific detection of different pathogens based on 16S rRNA can be achieved via a single Rptr.

Read this article:
TracrRNA reprogramming enables direct PAM-independent detection of RNA with diverse DNA-targeting Cas12 nucleases - Nature.com

Further information about the future of the controversial University of Cambridge project is expected to be shared later in 2024, Liam ODell can reveal.

Spectrum 10K was paused by researchers in September 2021 in order to carry out a consultation with the autism community, with the three-stage process concluding in May 2023.

However, the final report from independent consultants Hopkins Van Mil (HVM) on the findings of the consultation survey remains unpublished more than a year later.

Spectrum 10K academics failed to meet three 2023 deadlines for the documents publication, and in January an update from HVM told stakeholders to exercise patience.

It read: We are now in the process of collating our responses to the consultation feedback and recommendations to explain what we have learnt, the changes we will make in how we conduct research studies and how and why we want to continue to engage with the autism community in a meaningful way.

We are aware that our consultation participants, and the autism community more broadly, are awaiting this information and we would like to ask for your patience while we finish this process.

The full independent report and our response will be published on both the Hopkin Van Mil website and the Spectrum 10K website in due course.

Except questions are still being asked of the studys future, after Spectrum 10Ks website went offline in March without explanation.

In that same month, following a Freedom of Information request being made to the University of Cambridge by Liam ODell, the institution said the report would be published in the coming months.

This is despite the university initially telling this website the publication was imminent.

Now, in a statement on Friday, the Health Research Authority (HRA) pointed to further developments coming later this year.

A spokesperson said: We know that the Spectrum 10k team are taking the time to review the project following their consultation.

We expect to receive an update from the team regarding next steps for the study later this year.

The watchdog, which oversees the ethics of research studies, continues to monitor the studys progress after concluding an investigation into the project in May 2022.

The regulator said its favourable opinion of Spectrum 10K still stands, but added some of the issues raised as part of the complaints process could have been considered during the original review.

While no payment is expected or necessary to access this content, if you would like to support Liams independent journalism, you can send a tip viathe donation form on the right.

This report is the latest in his series The Spectrum 10K Files, with the full story of the controversial autism project explored in his upcoming non-fiction book, Selling Out the Spectrum to be published in late 2024.

Read the previous articlesonline now:

Original post:
Spectrum 10K: Update on autism DNA study expected later this year - Liam O'Dell

Thank you for reading D.C. Witness. Help us continue our mission into 2024.

By Sonia Vazquez , Lindsay Mutzman - July 18, 2024 Court | Daily Stories | Non-Fatal Shooting | Suspects | Victims |

A shooting defendant waived his right to independently test DNA evidence recovered from a crime scene before DC Superior Court Judge Robert Salerno on July 17.

Jonathan Dawkins, 42, is charged with assault with a dangerous weapon, possession of a firearm during a crime of violence, unlawful possession of a firearm by a prior convict, and threat to kidnap or injure a person, for his alleged involvement in a shooting that took place on the 700 block of G Street, SE, on April 24, 2023. No injuries were reported.

In court, the prosecution alerted the court that, despite recovering multiple items including cartridge casings, a car, and two phones, they would not be conducting any DNA testing.

Likewise, Dominique Winters, Dawkins defense attorney, alerted the court of his intent to waive his right to independent DNA testing.

Parties are slated to return on Dec. 20.

Read the original:
Shooting Defendant Waives Right to Independent DNA Testing - DC Witness